Raltitrexed (Tomudex™) in combination with 5-fluorouracil for the treatment of patients with advanced colorectal cancer: preliminary results from phase I clinical trials

Phase I Clinical Trials ◽

A PHARMACOKINETIC ANALYSIS OF TWO NOVEL MONOCLONAL ANTIBODIES: PRELIMINARY RESULTS FROM PHASE I CLINICAL TRIALS

Clinical Nuclear Medicine ◽

10.1097/00003072-199110000-00039 ◽

1991 ◽

Vol 16 (10) ◽

pp. 794

Author(s):

SA McQuarrie ◽

AJB McEwan ◽

L Golberg ◽

GD MacLean ◽

TR Sykes ◽

...

Keyword(s):

Clinical Trials ◽

Monoclonal Antibodies ◽

Phase I ◽

Pharmacokinetic Analysis ◽

Phase I Clinical Trials ◽

Phase I Clinical Trials of TX803 to Begin for Colorectal Cancer Patients

Oncology Times ◽

10.1097/01.cot.0000516165.63364.8e ◽

2017 ◽

Vol 39 (8) ◽

pp. 10 ◽

Cited By ~ 1

Keyword(s):

Colorectal Cancer ◽

Clinical Trials ◽

Phase I ◽

Cancer Patients ◽

Phase I Clinical Trials ◽

Colorectal Cancer Patients

A National Cancer Institute of Canada Clinical Trials Group Study – IND.135: Phase I/II study of irinotecan (camptosar), oxaliplatin and raltitrexed (tomudex) (COT) in patients with advanced colorectal cancer

European Journal of Cancer ◽

10.1016/j.ejca.2005.08.037 ◽

2006 ◽

Vol 42 (2) ◽

pp. 193-199 ◽

Cited By ~ 4

Author(s):

J.A. Maroun ◽

D. Jonker ◽

L. Seymour ◽

R. Goel ◽

M. Vincent ◽

...

Keyword(s):

Colorectal Cancer ◽

Clinical Trials ◽

Phase I ◽

National Cancer Institute ◽

Advanced Colorectal Cancer

93 POSTER Phase I study of daily oral AZD2171, an inhibitor of the vascular endothelial growth factor receptors (VEGFR), in combination with oxaliplatin and Infusional 5-Fu (mFOLFOX6) in patients with advanced colorectal cancer (CRC): a study of the National Cancer Institute of Canada Clinical Trials Group

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(06)70099-4 ◽

2006 ◽

Vol 4 (12) ◽

pp. 32 ◽

Cited By ~ 1

Author(s):

E. Chen ◽

D. Jonker ◽

M. Maclean ◽

J. Wells ◽

S. Mathews ◽

...

Keyword(s):

Colorectal Cancer ◽

Vascular Endothelial Growth Factor ◽

Clinical Trials ◽

Growth Factor ◽

Phase I ◽

National Cancer Institute ◽

Phase I Study ◽

Vascular Endothelial ◽

Endothelial Growth Factor

Raltitrexed (Tomudex™) in combination with platinum-based agents and/or anthracyclines: preliminary results of phase I clinical trials

European Journal of Cancer ◽

10.1016/s0959-8049(99)00043-x ◽

1999 ◽

Vol 35 ◽

pp. S14-S18 ◽

Cited By ~ 9

Author(s):

J.-P Armand ◽

L Seymour ◽

T.R.J Evans

Keyword(s):

Clinical Trials ◽

Phase I ◽

Phase I Clinical Trials ◽

Abstract 1287: Profile-related evidence to determine individualized cancer therapy (PREDICT): Preliminary results of the Personalized Phase I Clinical Trials program at MD Anderson Cancer Center

10.1158/1538-7445.am2011-1287 ◽

2011 ◽

Cited By ~ 2

Author(s):

Apostolia Maria Tsimberidou ◽

David S. Hong ◽

Jennifer J. Wheler ◽

Siqing Fu ◽

Sarina Piha-Paul ◽

...

Keyword(s):

Clinical Trials ◽

Cancer Therapy ◽

Phase I ◽

Cancer Center ◽

Phase I Clinical Trials ◽

Preliminary Results ◽

Md Anderson ◽

Individualized Cancer Therapy

Irinotecan (CPT-11) in combination with raltitrexed (TX) in patients with previously untreated, advanced colorectal cancer (ACC) patients. Preliminary results of a phase I/II trial

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.90140.3675 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 3675-3675

Author(s):

F. Losa ◽

H. Manzano ◽

P. Vicente ◽

J. Rifa ◽

J. Ocaña ◽

...

Keyword(s):

Colorectal Cancer ◽

Phase I ◽

Irinotecan (CPT-11) in combination with raltitrexed (TX) in patients with previously untreated, advanced colorectal cancer (ACC) patients. Preliminary results of a phase I/II trial

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.14_suppl.3675 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 3675-3675

Author(s):

F. Losa ◽

H. Manzano ◽

P. Vicente ◽

J. Rifa ◽

J. Ocaña ◽

...

Keyword(s):

Colorectal Cancer ◽

Phase I ◽

Molecular Profiling of Patients with Colorectal Cancer and Matched Targeted Therapy in Phase I Clinical Trials

Molecular Cancer Therapeutics ◽

10.1158/1535-7163.mct-12-0290 ◽

2012 ◽

Vol 11 (9) ◽

pp. 2062-2071 ◽

Cited By ~ 64

Author(s):

Rodrigo Dienstmann ◽

Danila Serpico ◽

Jordi Rodon ◽

Cristina Saura ◽

Teresa Macarulla ◽

...

Keyword(s):

Colorectal Cancer ◽

Clinical Trials ◽

Targeted Therapy ◽

Phase I ◽

Molecular Profiling ◽

Phase I Clinical Trials

Signal transduction inhibition: Results from phase I clinical trials in chronic myeloid leukemia

Seminars in Hematology ◽

10.1053/shem.2001.27079 ◽

2001 ◽

Vol 38 (3, Suppl 8) ◽

pp. 9-14 ◽

Cited By ~ 7

Author(s):

Brian Druker

Keyword(s):

Signal Transduction ◽

Clinical Trials ◽

Chronic Myeloid Leukemia ◽

Phase I ◽

Myeloid Leukemia ◽

Phase I Clinical Trials